Siemens Healthineers AG (ETR:SHL)
47.58
-0.40 (-0.83%)
May 6, 2025, 2:52 PM CET
Revenue by Product
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Imaging | 12.49B |
Log In |
Log In |
Log In |
Log In |
Imaging Growth | 4.99% |
Log In |
Log In |
Log In |
Log In |
Diagnostics | 4.43B |
Log In |
Log In |
Log In |
Log In |
Diagnostics Growth | -0.29% |
Log In |
Log In |
Log In |
Log In |
Advanced Therapies | 2.10B |
Log In |
Log In |
Log In |
Log In |
Advanced Therapies Growth | 3.91% |
Log In |
Log In |
Log In |
Log In |
Eliminations from | -274.00M |
Log In |
Log In |
Log In |
Log In |
Eliminations from Growth | -1.08% |
Log In |
Log In |
Log In |
Log In |
Varian | 3.93B |
Log In |
Log In |
Log In |
Log In |
Varian Growth | 6.13% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
EMEA | 7.44B |
Log In |
Log In |
Log In |
Log In |
EMEA Growth | 4.06% |
Log In |
Log In |
Log In |
Log In |
Americas | 9.72B |
Log In |
Log In |
Log In |
Log In |
Americas Growth | 9.52% |
Log In |
Log In |
Log In |
Log In |
Asia and Australia Revenue (Pre-FY2023 Reporting) | - |
Log In |
Log In |
Log In |
Log In |
Asia and Australia Revenue (Pre-FY2023 Reporting) Growth | - |
Log In |
Log In |
Log In |
Log In |
Asia Pacific Japan Revenue (Post-FY2022 Reporting) | 3.00B |
Log In |
Log In |
Log In |
Log In |
Asia Pacific Japan Revenue (Post-FY2022 Reporting) Growth | 1.97% |
Log In |
Log In |
Log In |
Log In |
China | 2.51B |
Log In |
Log In |
Log In |
Log In |
China Growth | -10.64% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is October - September.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Imaging Income Before Taxes | 2.62B |
Log In |
Log In |
Log In |
Log In |
Imaging Income Before Taxes Growth | 6.00% |
Log In |
Log In |
Log In |
Log In |
Diagnostics Income Before Taxes | 264.00M |
Log In |
Log In |
Log In |
Log In |
Diagnostics Income Before Taxes Growth | 53.70% |
Log In |
Log In |
Log In |
Log In |
Advanced Therapies Income Before Taxes | 340.00M |
Log In |
Log In |
Log In |
Log In |
Advanced Therapies Income Before Taxes Growth | 2.94% |
Log In |
Log In |
Log In |
Log In |
Eliminations from Income Before Taxes | -1.29B |
Log In |
Log In |
Log In |
Log In |
Eliminations from Income Before Taxes Growth | 4.28% |
Log In |
Log In |
Log In |
Log In |
Varian Income Before Taxes | 660.00M |
Log In |
Log In |
Log In |
Log In |
Varian Income Before Taxes Growth | 14.48% |
Log In |
Log In |
Log In |
Log In |
Equipment Book-to-Bill Ratio | - |
Log In |
Log In |
Log In |
Log In |